• Download factsheet
  • Request info pack
  • Request a call
  • Request Lonsec research

Thank you for your request, an email will be sent to you shortly. If you don’t receive it within 30 minutes please contact info@betashares.com.au

OVERVIEW

About

Provides simple, cost-effective and transparent exposure to the largest companies in the global healthcare sector

  • Tactical exposure to the global healthcare sector
  • A core component of a global equities allocation providing transparency and diversification benefits

Advantages

  • Access – simple way to access a diversified portfolio of the world’s largest healthcare companies
  • Reduced currency risk – foreign currency exposure hedged to the Australian dollar
  • Diversification – with a single trade, investors can get exposure to a diversified portfolio of healthcare companies from a broad range of global locations
  • Cost effective – Fund aims to track the performance of an index (no ‘active manager’ fees)
  • Large company exposure – strategy invests only in the most significant healthcare companies globally
  • No W-8 BEN forms and no US estate tax implications for investors – simplified tax administration, unlike cross-listed alternatives
  • Liquidity – available to trade on ASX like any share

How to Invest

  • You can buy or sell units just like you’d buy or sell any share on the ASX
  • Fund requires no minimum investment

KEY FACTS

Pricing Information 24 September 2017

Current Price
Last Trade* $5.48
% Change (prev day) -0.54%
Bid (delayed) $5.45
Offer (delayed) -
*Data is delayed by at least 20 minutes.
Download NAV history
NAV
NAV/Unit * $5.46
* As at 22 September 2017

Profile

Net Assets* ($A) $19,667,208
Units Outstanding* (#) 3,600,000
Mgmt Costs** (% p.a.) 0.57%
Distribution Frequency Semi-annual
Distribution Reinvestment Plan (DRP) Full or partial participation available
Issuer BetaShares Capital Ltd
Fund Administrator RBC Investor Services
Custodian RBC Investor Services
Registry Link Market Services
Auditor KPMG
* As at 22 September 2017
**Certain additional costs apply. Please refer to PDS.

Trading Information

ASX Code DRUG
Bloomberg Code DRUG AU
IRESS Code DRUG.AXW
Trading Hours 10.00-16.00 (AEST)
iNAV IRESS Code N/A
Market Makers Deutsche Securities
SMSF Eligible Yes

Index Information

Index Nasdaq Global ex-Australia Healthcare Hedged AUD Index
Index Provider Nasdaq
Index Ticker N/A
Bloomberg Index Ticker NQXAUHHN INDEX
Index Methodology

Top Exposures

Name %
Johnson & Johnson 8.0 %
Novartis AG 6.4 %
Pfizer Inc 5.5 %
Roche Holding AG 5.2 %
Merck & Co Inc 4.7 %
UnitedHealth Group Inc 4.4 %
Sanofi 3.1 %
Medtronic PLC 3.0 %
Amgen Inc 3.0 %
Celgene Corp 2.9 %
As of close of trading 31/08/2017
The information above shows underlying share exposures of the Fund.

Sector Allocation

Healthcare
100.0%
0
0.0%
* As of 31 August 2017

Country Allocation

United States
66.1%
Switzerland
11.8%
Britain
4.7%
Japan
4.6%
France
3.9%
Ireland
3.0%
Denmark
2.8%
Germany
2.0%
Netherlands
1.1%
Other
0.0%
* As of 31 August 2017

PERFORMANCE

Fund Returns After Fees (%)

  Fund Index
1 month 1.55% 1.57%
3 months 3.92% 4.07%
6 months 7.36% 7.55%
1 year 12.03% 12.54%
3 year p.a - -
5 year p.a - -
Since inception (p.a) 7.31% 7.70%
Inception date 4-Aug-16 -
* As at 31 August 2017

Chart

Past performance is not an indicator of future performance. Returns are calculated in Australian dollars using net asset value per unit at the start and end of the specified period and do not reflect brokerage or the bid ask spread that investors incur when buying and selling units on the ASX. Returns are after fund management costs, assume reinvestment of any distributions and do not take into account tax paid as an investor in the Fund. Returns for periods longer than one year are annualised. Current performance may be higher or lower than the performance shown.

DISTRIBUTIONS

Yield Information

Distribution Frequency Semi-Annual
12 Mth Distribution Yield* (%) -
12 Mth Gross Distribution Yield* (%) -
Franking Level -
* As of 31 August 2017. Yield figures are calculated by summing the prior 12 month fund per unit distributions divided by the fund closing NAV per unit at quarter-end. Past performance is not an indicator of future performance.

Recent Distributions

Ex Date Record Date Payment Date Distribution Unit ($) Annual Distribution Return (%) (1)
- - - - -
View more
1 This is the annual distribution return to the end of the relevant distribution date. The distribution return reflects the contribution to total investment return made by the Fund's distributions. It is calculated as the difference between total Fund return and NAV return. NAV return is the change in the Fund's NAV price. Total return is the NAV return plus reinvestment of all distributions back to the Fund. Past performance not indicative of future performance.

ANNOUNCEMENTS

ASX Announcements: DRUG

Download
Showing - of

RESOURCES

Factsheet - DRUG
Download
The Investment Case for DRUG
Download
Portfolio Holdings
Download
Index Methodology
Download
Annual Financial Report June 2016
Download
Supplementary Product Disclosure Statement – November 2016
Download
Supplementary Product Disclosure Statement - January 2017
Download
Product Disclosure Statement - MNRS, FUEL, FOOD, HACK, BNKS, DRUG
Download
31 December 2016 Interim Financial Report - International Equity Funds
Download
View more

LEARN MORE ABOUT DRUG

Request an info pack